AN2 Therapeutics Inc.
ANTX | NASDAQ
$4.53
-$0.16 (-3.41%)
At close: Oct 30, 2026, 4:00 PM ET
$4.53
$0.00 (0.00%)
Pre-market:
Nov 2, 2026, 5:27 AM ET
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -8.9M | -10.55M | -9.32M | -10.04M | -7.22M | -11.54M | -8.6M | -14.01M | -15.88M | -18.3M | -18.82M | -18.18M | -16.6M | -16.04M | -12.48M | -11.77M | -10.33M | -7.68M | -7.59M | -6.93M | -5M | -2.05M |
Interest Income | 720K | 523K | 605K | 687K | 754K | 888K | n/a | 1.27M | 1.45M | 1.68M | n/a | n/a | n/a | n/a | 630K | 466K | 228K | 27K | 27K | 25K | 15K | 2K |
Pretax Income | -8.19M | -10.03M | -8.71M | -9.35M | -6.46M | -10.65M | -7.52M | -12.75M | -14.44M | -16.62M | -16.9M | -16.71M | -15.8M | -15.32M | -11.84M | -11.34M | -10.12M | -7.66M | -7.55M | -6.94M | -5.01M | -2.05M |
Net Income | -8.19M | -10.03M | -8.71M | -9.35M | -6.46M | -10.65M | -7.52M | -12.75M | -14.44M | -16.62M | -16.9M | -16.71M | -15.8M | -15.32M | -11.84M | -11.34M | -10.12M | -7.66M | -7.55M | -6.94M | -5.01M | -2.05M |
Selling & General & Admin | 2.89M | 3.81M | 2.44M | 3.04M | 4.02M | 3.85M | 3.21M | 3.48M | 3.73M | 3.64M | 3.9M | 3.75M | 3.06M | 4.05M | 3.72M | 3.34M | 3.64M | 2.05M | 1.78M | 1.59M | 898K | 401K |
Research & Development | 6.02M | 6.74M | 6.88M | 7M | 3.2M | 7.69M | 5.4M | 8.29M | 12.15M | 14.66M | 14.92M | 14.43M | 13.54M | 11.99M | 8.75M | 8.43M | 6.7M | 5.63M | 5.81M | 5.35M | 4.1M | 1.65M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -9K | 2.24M | n/a | n/a | n/a | n/a | n/a | 0 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 8.9M | 10.55M | 9.32M | 10.04M | 7.22M | 11.54M | 8.6M | 14.01M | 15.88M | 18.3M | 18.82M | 18.18M | 16.6M | 16.04M | 12.48M | 11.77M | 10.33M | 7.68M | 7.59M | 6.93M | 5M | 2.05M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.9M | 10.55M | 9.32M | 10.04M | 7.22M | 11.54M | 8.6M | 14.01M | 15.88M | 18.3M | 18.82M | 18.18M | 16.6M | 16.04M | 12.48M | 11.77M | 10.33M | 7.68M | 7.59M | 6.93M | 5M | 2.05M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 44.76M | 34.06M | 30.22M | 30.28M | 30.17M | 30.05M | 29.88M | 29.84M | 29.83M | 29.76M | 29.74M | 25.65M | 19.5M | 19.39M | 19.4M | 19.35M | 19.26M | 19M | 18.14M | 14.05M | 14.05M | 14.05M |
Shares Outstanding (Diluted) | 44.76M | 34.06M | 30.22M | 30.28M | 30.17M | 30.05M | 29.88M | 29.84M | 29.83M | 29.76M | 29.74M | 25.65M | 19.5M | 19.39M | 19.4M | 19.35M | 19.26M | 19M | 18.14M | 14.05M | 14.05M | 14.05M |
EPS (Basic) | -0.18 | -0.29 | -0.29 | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.57 | -0.65 | -0.81 | -0.75 | -0.66 | -0.56 | -0.52 | -0.40 | -0.42 | -0.63 | -0.49 | -0.20 |
EPS (Diluted) | -0.18 | -0.29 | -0.29 | -0.31 | -0.21 | -0.35 | -0.25 | -0.43 | -0.48 | -0.56 | -0.57 | -0.65 | -0.81 | -0.75 | -0.66 | -0.56 | -0.52 | -0.40 | -0.42 | -0.63 | -0.49 | -0.20 |
EBITDA | -8.19M | -10.03M | -10M | -9.35M | -6.46M | -10.65M | n/a | -11.77M | 10.97M | -16.62M | -16.48M | 1.47M | -15.8M | 716K | -11.84M | -11.34M | -10.12M | -7.66M | 49K | -6.94M | -5.01M | -2.05M |
EBIT | -8.19M | -10.03M | -10M | -9.35M | -6.46M | -10.65M | -8.61M | -11.77M | -14.44M | -16.62M | -16.9M | -16.71M | -15.8M | -15.32M | -11.84M | -11.34M | -10.12M | -7.66M | -7.55M | -6.94M | -5.01M | -2.05M |
Depreciation & Amortization | n/a | n/a | n/a | n/a | n/a | n/a | 8.61M | n/a | 25.41M | n/a | 414K | 18.18M | n/a | 16.04M | n/a | n/a | n/a | n/a | 7.59M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove ANTX